Liproxenol Nutraceuticals reports record demand for all-natural diet supplement Liproxenol
Diet pill Liproxenol most popular in a new class of diet supplements that promote safe, effective weight loss without artificial ingredients
Auckland, New Zealand (PRWEB) February 13, 2013
Liproxenol Nutraceuticals CEO Sam Samson today announced that Q4 ’12 sales of its diet supplement Liproxenol reached a new high. Among weight loss products available internationally,Liproxenol now ranks as one of the fastest-sellers and most popular in history.
In the wake of highly-publicized health scares involving lab-engineered diet supplements rife with dangerous artificial ingredients, Liproxenol turned its research toward developing a safe and effective diet pill using only 100% natural ingredients. Liproxenol is the result of that work and leverages a blend of eleven traditional ingredients to power weight loss, including green tea extract, Vitamin B6, and guarana extract.
“We are obviously very pleased with consumer response to Liproxenol,” said Mr. Samson. “This diet pill is the result of extensive formulation and testing, with an unprecedented goal of absolute safety without compromising weight loss performance. We are proud to be able to help our customers lose weight and enjoy the quality of life and satisfaction that they deserve.”
The enthusiastic demand for Liproxenol is fueling expansion into additional territories. Their products will soon be available in over 105 countries worldwide; product descriptions and direct customer care can be found at the Liproxenol website.
About Liproxenol Nutraceuticals:
Liproxenol Nutraceuticals is a leading provider of innovative healthy living supplements and well being products to markets around the globe. Customers count on Liproxenol to provide the cutting edge products and solutions to help them create strong minds and fit bodies, and allow them to enjoy life to the fullest extent and with the greatest satisfaction possible. Liproxenol operates fulfillment and manufacturing in New Zealand and the USA.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/2/prweb10420697.htm